Iridex (IRIX) Research & Development (2010 - 2026)

Iridex's Research & Development history runs 17 years deep, the most recent figure standing at $2.5 million for Q2 2026.

• On a quarterly basis, Research & Development rose 189.61% year-over-year to $2.5 million in Q2 2026; TTM through Apr 2026 was $10.5 million, a 70.8% increase from a year earlier, with the FY2026 full-year figure at $10.4 million, up 90.79% from the prior year.
• Research & Development fell to $2.5 million in Q2 2026 per IRIX's latest filing, from $2.8 million in the prior quarter.
• Across five years, Research & Development topped out at $12.5 million in Q4 2022 and bottomed at -$5.5 million in Q4 2023.
• The 5-year median for Research & Development is $2.7 million (2024), against an average of $2.9 million.
• Across the five-year window, Research & Development plunged 144.5% in 2023 and jumped 189.61% in 2026, its largest moves.
• Year by year, Research & Development stood at $12.5 million in 2022, then plunged by 144.5% to -$5.5 million in 2023, then soared by 120.09% to $1.1 million in 2024, then jumped by 138.72% to $2.7 million in 2025, then fell by 4.52% to $2.5 million in 2026.
• Per Business Quant, the three latest IRIX Research & Development figures stand at $2.5 million (Q2 2026), $2.8 million (Q1 2026), and $2.7 million (Q3 2025).